{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:51Z","timestamp":1786995651161,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC Career Development Fellowship","doi-asserted-by":"publisher","award":["APP1066916"],"award-info":[{"award-number":["APP1066916"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council Future Fellowship","doi-asserted-by":"publisher","award":["FT170100431"],"award-info":[{"award-number":["FT170100431"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Research Training Program"},{"DOI":"10.13039\/501100000925","name":"NHMRC Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.phrs.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T11:02:19Z","timestamp":1528455739000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period"],"prefix":"10.1016","volume":"134","author":[{"given":"Jia Yin","family":"Soo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Caroline","family":"McMillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8602-8519","authenticated-orcid":false,"given":"Janna L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0005","first-page":"490","article-title":"Intrauterine growth restriction","volume":"99","author":"Resnik","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.phrs.2018.06.003_bib0010","series-title":"Australia\u2019s Mothers and Babies 2015\u2014in Brief, Perinatal Statistics Series No. 33 Cat No. PER 91(Canberra: AIHW)","author":"Australian Institute of Health and Welfare","year":"2017"},{"issue":"5","key":"10.1016\/j.phrs.2018.06.003_bib0015","doi-asserted-by":"crossref","first-page":"1592S","DOI":"10.1093\/jn\/133.5.1592S","article-title":"The epidemiology of adverse pregnancy outcomes: an overview","volume":"133","author":"Kramer","year":"2003","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1365.012","article-title":"Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome","volume":"1092","author":"Valsamakis","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00003081-200606000-00008","article-title":"Perinatal outcome and later implications of intrauterine growth restriction","volume":"49","author":"Pallotto","year":"2006","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.phrs.2018.06.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/839656","article-title":"Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?","author":"Morrison","year":"2012","journal-title":"J. Pregnancy"},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physrev.00053.2003","article-title":"Developmental origins of the metabolic syndrome: prediction, plasticity, and programming","volume":"85","author":"McMillen","year":"2005","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2018.06.003_bib0040","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1440-1681.2008.04975.x","article-title":"Sheep models of intrauterine growth restriction: fetal adaptations and consequences","volume":"35","author":"Morrison","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/physiol.00050.2005","article-title":"Intrauterine programming of physiological systems: causes and consequences","volume":"21","author":"Fowden","year":"2006","journal-title":"Physiology"},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/jrf.0.0070289","article-title":"Studies on the placenta of the sheep (Ovis aries L.)","volume":"7","author":"Alexander","year":"1964","journal-title":"J. Reprod. Fertil."},{"issue":"4","key":"10.1016\/j.phrs.2018.06.003_bib0055","doi-asserted-by":"crossref","first-page":"L575","DOI":"10.1152\/ajplung.00226.2009","article-title":"Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus","volume":"298","author":"Orgeig","year":"2010","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1113\/jphysiol.2004.080523","article-title":"Restriction of placental growth results in greater hypotensive response to \u03b1\u2010adrenergic blockade in fetal sheep during late gestation","volume":"563","author":"Danielson","year":"2005","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0065","first-page":"173","article-title":"Effect of hyperthermia on the plasma concentrations of prolactin and cortisol in the fetal lamb and pregnant ewe during late gestation","volume":"13","author":"Walker","year":"1990","journal-title":"J. Dev. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2018.06.003_bib0070","doi-asserted-by":"crossref","first-page":"E516","DOI":"10.1152\/ajpendo.00435.2012","article-title":"Reductions in insulin concentrations and \u03b2-cell mass precede growth restriction in sheep fetuses with placental insufficiency","volume":"304","author":"Limesand","year":"2013","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ajog.2009.07.028","article-title":"Cardiovascular responses to maternal betamethasone administration in the intrauterine growth\u2013restricted ovine fetus","volume":"201","author":"Miller","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0080","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0002-9378(94)70309-4","article-title":"Fetal endocrine responses to chronic placental embolization in the late-gestation ovine fetus","volume":"170","author":"Gagnon","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.phrs.2018.06.003_bib0085","doi-asserted-by":"crossref","first-page":"e12614","DOI":"10.14814\/phy2.12614","article-title":"Induction of controlled hypoxic pregnancy in large mammalian species","volume":"3","author":"Brain","year":"2015","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1113\/jphysiol.2006.105072","article-title":"Recent observations on the regulation of fetal metabolism by glucose","volume":"572","author":"Hay","year":"2006","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0095","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/JOE-17-0076","article-title":"The impact of IUGR on pancreatic islet development and \u03b2-cell function","volume":"235","author":"Boehmer","year":"2017","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/en.2014-1393","article-title":"Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus","volume":"156","author":"Andrews","year":"2015","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0105","doi-asserted-by":"crossref","first-page":"E1716","DOI":"10.1152\/ajpendo.00459.2007","article-title":"Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction","volume":"293","author":"Limesand","year":"2007","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0110","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.1152\/ajpendo.00639.2007","article-title":"Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1\u03b1 mRNA and phosphorylated CREB in fetal sheep","volume":"294","author":"Rozance","year":"2008","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0115","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2337\/db14-0462","article-title":"Placental insufficiency decreases pancreatic vascularity and disrupts hepatocyte growth factor signaling in the pancreatic islet endothelial cell in fetal sheep","volume":"64","author":"Rozance","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0120","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1210\/en.2006-0653","article-title":"Placental restriction of fetal growth increases insulin action, growth, and adiposity in the young lamb","volume":"148","author":"De Blasio","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0125","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1113\/jphysiol.2007.142141","article-title":"Restriction of placental growth in sheep impairs insulin secretion but not sensitivity before birth","volume":"584","author":"Owens","year":"2007","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1095\/biolreprod.108.073569","article-title":"Intrauterine growth restriction and differential patterns of hepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in the sheep fetus in late gestation","volume":"80","author":"Gentili","year":"2009","journal-title":"Biol. Reprod."},{"issue":"9243","key":"10.1016\/j.phrs.2018.06.003_bib0135","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0140-6736(00)03209-8","article-title":"Prescription of drugs during pregnancy in France","volume":"356","author":"Lacroix","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.phrs.2018.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00228-008-0546-y","article-title":"Prescription drug use during pregnancy: a population-based study in regione Emilia-romagna, Italy","volume":"64","author":"Gagne","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0145","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1208\/aapsj080112","article-title":"Cytochrome P450s and other enzymes in drug metabolism and toxicity","volume":"8","author":"Guengerich","year":"2006","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.phrs.2018.06.003_bib0150","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.phrs.2018.06.003_bib0155","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1124\/dmd.109.026609","article-title":"Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17\u03b2-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy","volume":"37","author":"Chen","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0160","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1124\/mol.58.6.1441","article-title":"Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation","volume":"58","author":"Pascussi","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2018.06.003_bib0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/03602532.2010.484462","article-title":"Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids","volume":"42","author":"Dvorak","year":"2010","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0170","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-09-0308","article-title":"Differences in expression and activity of 11\u03b2-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender","volume":"161","author":"Mericq","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0175","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1203\/00006450-199612000-00014","article-title":"Placental restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus during late gestation","volume":"40","author":"Phillips","year":"1996","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000263348","article-title":"Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses","volume":"3","author":"Economides","year":"1988","journal-title":"Fetal Diagn. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000200042.64517.19","article-title":"Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction","volume":"47","author":"Salas","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.06.003_bib0190","series-title":"RCOG Green-Top Guideline, No. 7: Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality","year":"2010"},{"issue":"12","key":"10.1016\/j.phrs.2018.06.003_bib0195","first-page":"2547","article-title":"Principles and standards for reporting animal experiments in","volume":"593","author":"Grundy","year":"2015","journal-title":"J. Physiol. Exp. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0200","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0205","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1469-7793.1999.897ab.x","article-title":"Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril","volume":"515","author":"Edwards","year":"1999","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0210","doi-asserted-by":"crossref","first-page":"R306","DOI":"10.1152\/ajpregu.00798.2006","article-title":"Restriction of placental function alters heart development in the sheep fetus","volume":"293","author":"Morrison","year":"2007","journal-title":"Am. J. Physiol.-Regul. Integr. Compar. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2018.06.003_bib0215","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1203\/00006450-200204000-00007","article-title":"Effect of maternal fluoxetine administration on uterine blood flow, fetal blood gas status, and growth","volume":"51","author":"Morrison","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phrs.2018.06.003_bib0220","first-page":"34","article-title":"Energy allowances and feeding systems for ruminants","volume":"33","author":"Aldermann","year":"1975","journal-title":"Minist. Agric. Fish. Food: Tech. Bull."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1203\/PDR.0b013e3181a7c121","article-title":"Intrauterine growth restriction and the sex specific programming of leptin and peroxisome proliferator-activated receptor gamma mRNA expression in visceral fat in the lamb","volume":"66","author":"Duffield","year":"2009","journal-title":"Pediatr. Res."},{"issue":"9","key":"10.1016\/j.phrs.2018.06.003_bib0230","doi-asserted-by":"crossref","first-page":"e0181185","DOI":"10.1371\/journal.pone.0181185","article-title":"Normalisation of surfactant protein-A and-B expression in the lungs of low birth weight lambs by 21 days old","volume":"12","author":"Soo","year":"2017","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.phrs.2018.06.003_bib0235","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.metabol.2013.06.013","article-title":"Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy","volume":"62","author":"Wang","year":"2013","journal-title":"Metabolism"},{"issue":"17","key":"10.1016\/j.phrs.2018.06.003_bib0240","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1113\/jphysiol.2009.173161","article-title":"The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscle","volume":"587","author":"Muhlhausler","year":"2009","journal-title":"J. Physiol."},{"issue":"19","key":"10.1016\/j.phrs.2018.06.003_bib0245","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1113\/jphysiol.2011.211185","article-title":"Fetal growth restriction and the programming of heart growth and cardiac insulin\u2010like growth factor 2 expression in the lamb","volume":"589","author":"Wang","year":"2011","journal-title":"J. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0250","doi-asserted-by":"crossref","first-page":"e12270","DOI":"10.14814\/phy2.12270","article-title":"Low birth weight activates the renin\u2013angiotensin system, but limits cardiac angiogenesis in early postnatal life","volume":"3","author":"Wang","year":"2015","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2018.06.003_bib0255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2018.06.003_bib0260","doi-asserted-by":"crossref","first-page":"e00130","DOI":"10.1002\/phy2.130","article-title":"The fetal sheep lung does not respond to cortisol infusion during the late canalicular phase of development","volume":"1","author":"McGillick","year":"2013","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-10-72","article-title":"Selection of reference genes for normalisation of real-time RT-PCR in brain-stem death injury in ovis aries","volume":"10","author":"Passmore","year":"2009","journal-title":"BMC Mol. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2018.06.003_bib0270","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/dmd.112.045245","article-title":"Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease","volume":"40","author":"Velenosi","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.phrs.2018.06.003_bib0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000457310","article-title":"Effect of protein depletion and intrauterine growth retardation on rat hepatic drug metabolism","volume":"6","author":"Sonawane","year":"1983","journal-title":"Dev. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2018.06.003_bib0280","series-title":"Seminars in Perinatology","first-page":"213","article-title":"Adult sequelae of intrauterine growth restriction","author":"Ross","year":"2008"},{"issue":"7549","key":"10.1016\/j.phrs.2018.06.003_bib0285","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2018.06.003_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408449209145319","article-title":"The human hepatic cytochromes P450 involved in drug metabolism","volume":"22","author":"Wrighton","year":"1992","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0295","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425255.1.3.429","article-title":"Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination","volume":"1","author":"Smith","year":"2005","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"10.1016\/j.phrs.2018.06.003_bib0300","series-title":"AMH: Australian Medicines Handbook 2017, Australian Medicines Handbook","author":"Australian Medicines Handbook Pty Ltd","year":"2017"},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1248\/bpb.31.231","article-title":"Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.phrs.2018.06.003_bib0310","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.31.11.1292","article-title":"Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918","volume":"31","author":"Wu","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.phrs.2018.06.003_bib0315","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","article-title":"Update on the use of antihypertensive drugs in pregnancy","volume":"51","author":"Podymow","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.06.003_bib0320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/IJWH.S6794","article-title":"Optimal management of nausea and vomiting of pregnancy","volume":"2","author":"Ebrahimi","year":"2010","journal-title":"Int. J. Women\u2019s Health"},{"issue":"16","key":"10.1016\/j.phrs.2018.06.003_bib0325","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMcp1003896","article-title":"Nausea and vomiting in pregnancy","volume":"363","author":"Niebyl","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2018.06.003_bib0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.300.2.355","article-title":"The ontogeny of human drug-metabolizing enzymes: phase i oxidative enzymes","volume":"300","author":"Hines","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2018.06.003_bib0335","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0169-409X(02)00075-3","article-title":"Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2\/ABCC2): its impact on drug disposition","volume":"54","author":"Suzuki","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"issue":"09","key":"10.1016\/j.phrs.2018.06.003_bib0345","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0033-1361933","article-title":"Medication use in the neonatal intensive care unit","volume":"31","author":"Hsieh","year":"2014","journal-title":"Am. J. Perinatol."},{"issue":"3","key":"10.1016\/j.phrs.2018.06.003_bib0350","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpeds.2007.07.050","article-title":"Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications","volume":"152","author":"Kumar","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2018.06.003_bib0355","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4860","article-title":"Medical history taking in adults should include questions about preterm birth","volume":"349","author":"Crump","year":"2014","journal-title":"BMJ: Br. Med. J. (Online)"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818301610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818301610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:54:50Z","timestamp":1760910890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818301610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":71,"alternative-id":["S1043661818301610"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.06.003","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}